ELMD
What one share of Electromed holds
Electromedical and Electrotherapeutic Apparatus
Electromed, Inc. (“we,” “our,” “us,” “Electromed” or the “Company”) develops, manufactures, markets and sells innovative products that provide airway clearance therapy, including the SmartVest® Airway Clearance System (“SmartVest System”) to patients with compromised pulmonary function with a commitment to excellence and compassionate service.
Electromed’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $8.49 |
|---|---|
| Profit | $1.30 |
| Capex (buildings and equipment) | $0.14 |
| Free cash flow | $0.97 |
| Cash and investments | $2.44 |
| Book value | $6.45 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2017 | $3.06 | $0.26 | $0.07 | $0.07 | — | $2.41 |
| 2018 | $3.28 | $0.21 | $0.06 | $0.22 | — | $2.72 |
| 2019 | $3.63 | $0.23 | $0.15 | $0.15 | — | $3.06 |
| 2020 | $3.68 | $0.47 | $0.10 | $0.38 | — | $3.53 |
| 2021 | $4.01 | $0.27 | $0.03 | $0.31 | — | $3.80 |
| 2022 | $4.75 | $0.26 | $0.16 | −$0.24 | — | $4.03 |
| 2023 | $5.52 | $0.36 | $0.19 | −$0.04 | — | $4.40 |
| 2024 | $6.17 | $0.58 | $0.03 | $0.99 | — | $5.16 |
| 2025 | $7.18 | $0.85 | $0.03 | $1.25 | — | $5.18 |
| 2026 | $8.49 | $1.30 | $0.14 | $0.97 | — | $6.45 |